复杂克罗恩病微创回结肠切除术的围手术期结局:转诊中心回顾性队列
该回顾性队列纳入274例接受微创回结肠切除术的克罗恩病患者,其中复杂克罗恩病84例(30.7%)。复杂组与无并发症组在术中并发症、中转率、术后并发症及住院时间上均无显著差异。结论认为复杂克罗恩病行微创回结肠切除术安全可行。
要点
- 复杂克罗恩病(合并瘘、脓肿或蜂窝织炎)行微创回结肠切除术安全可行。
- 复杂组与无并发症组的术中并发症、中转率、术后并发症及住院时间无显著差异。
- 复杂组营养不良比例更高(32.1% vs 16.1%,P=.004),既往因克罗恩病行肠切除比例更高(22.1% vs 9.5%,P=.002)。
核心结论
- 复杂克罗恩病行微创回结肠切除术安全可行,未来需前瞻性研究确认。
研究设计与样本
- 转诊中心回顾性队列,纳入2014至2021年连续成人克罗恩病行微创回结肠切除术患者274例。
主要发现
- 274例中机器人入路101例(36.9%),复杂克罗恩病84例(30.7%)。
- 复杂组营养不良比例32.1% vs 无并发症组16.1%(P=.004)。
- 复杂组既往因克罗恩病行肠切除比例22.1% vs 无并发症组9.5%(P=.002)。
- 术中并发症无并发症组1.1% vs 复杂组2.4%(P=.463),中转率2.6% vs 4.8%(P=.463)。
- 术后并发症无并发症组27.4% vs 复杂组34.5%(P=.231),腹腔感染性并发症4.2% vs 7.1%(P=.309),住院时间3.8±2.0天 vs 4.2±3.0天(P=.188)。
临床怎么用
- 复杂克罗恩病(合并瘘、脓肿或蜂窝织炎)可考虑微创回结肠切除术,但需注意复杂组营养不良和既往肠切除比例更高。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive ileocolic resection for complicated Crohn disease, defined as penetrating Crohn disease associated with intra-abdominal fistula, abscess, or phlegmon, is challenging. In addition, the impact of the minimally invasive approach on postoperative outcomes is still debated. This study aimed to compare the intraoperative and postoperative outcomes of minimally invasive ileocolic resection for complicated versus uncomplicated Crohn disease. METHODS: A retrospective analysis of all consecutive adult patients with Crohn disease undergoing minimally invasive ileocolic resection from 2014 to 2021 was performed. Perioperative outcomes were compared between patients with complicated Crohn disease (complicated group) and patients without these lesions (uncomplicated group). RESULTS: Among the 274 patients undergoing minimally invasive ileocolic resection for Crohn disease, 101 (36.9%) had a robotic approach, and 84 (30.7%) had complicated Crohn disease. Complicated patients were more frequently malnourished (32.1% vs 16.1%, P = .004) and had more frequent previous bowel resections for Crohn disease (22.1% vs 9.5%, P = .002). There were no differences between both groups regarding intraoperative complications (1.1% uncomplicated group vs 2.4% complicated group, P = .463), conversion rate (2.6% uncomplicated group vs 4.8% complicated group, P = .463), postoperative morbidity (27.4% uncomplicated group vs 34.5% complicated group, P = .231), intra-abdominal septic complications (4.2% uncomplicated group vs 7.1% complicated group, P = .309), and length of stay (3.8 ± 2.0 days uncomplicated group vs 4.2 ± 3.0 complicated group, P = .188). CONCLUSION: Minimally invasive ileocolic resection for complicated Crohn disease is safe and feasible. Future prospective studies are needed to confirm these results.
引用
- Abdalla S, Abd El Aziz MA, Calini G, et al. Perioperative outcomes of minimally invasive ileocolic resection for complicated Crohn disease: Results from a referral center retrospective cohort. Surgery. 2022. PMID: 35337682. doi:10.1016/j.surg.2022.01.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。